Teosyal Rha 1 (2x1 ml)

The RHA technology preserves the natural HA structure, allowing the gel to act as a flexible mesh in the superficial dermis. Unlike traditional skin boosters, RHA 1 provides long-term mechanical correction of fine lines while maintaining the skin's elasticity during active facial expressions.

This treatment is strictly contraindicated. No clinical safety data exists for HA injectables during pregnancy. We defer all elective aesthetic treatments until after childbirth and the cessation of breastfeeding.

Injection is not recommended for nursing mothers. It is advised to postpone elective aesthetic procedures until the breastfeeding period has completely concluded to ensure maximum safety.

The formulation contains 15 mg/ml of Resilient Hyaluronic Acid (cross-linked and non-cross-linked) and 0.3% Lidocaine hydrochloride for procedural comfort.

Dosage is individualized based on the depth of the superficial lines and the surface area of the treatment (e.g., neck vs. perioral). Typically, 1 ml is sufficient for a full perioral refresh. Practitioners should evaluate if 0.5 ml of filler is enough for initial hydration in sensitive zones before utilizing the full pack for broader rejuvenation.

Expect transient effects such as mild swelling, redness, and potential purple bruising. Because RHA 1 is highly fluid, inflammatory responses are generally lower than with denser fillers. Follow our expert aftercare guide to ensure a quick recovery. Any persistent blanching requires immediate evaluation per our safety protocol.

Patients should avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase blood flow to the injection site, potentially worsening post-filler swelling and bruising in delicate areas like the neck or eyes.